IRIS
CONTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.632
EU - Europa 1.365
AS - Asia 1.082
SA - Sud America 237
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 5.402
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.592
SG - Singapore 342
CN - Cina 224
IT - Italia 224
RU - Federazione Russa 208
UA - Ucraina 203
VN - Vietnam 199
BR - Brasile 191
DE - Germania 154
SE - Svezia 153
IE - Irlanda 110
TR - Turchia 94
FR - Francia 74
DK - Danimarca 72
FI - Finlandia 59
GB - Regno Unito 51
CI - Costa d'Avorio 50
HK - Hong Kong 48
IN - India 40
KR - Corea 39
BD - Bangladesh 25
CA - Canada 18
AR - Argentina 16
MX - Messico 16
NL - Olanda 14
ZA - Sudafrica 13
PL - Polonia 12
IQ - Iraq 11
CO - Colombia 8
EC - Ecuador 8
ES - Italia 8
ID - Indonesia 8
JP - Giappone 8
MA - Marocco 7
PH - Filippine 6
BE - Belgio 5
EU - Europa 5
MY - Malesia 5
SA - Arabia Saudita 5
VE - Venezuela 5
AT - Austria 4
EG - Egitto 4
LT - Lituania 4
JO - Giordania 3
LB - Libano 3
PK - Pakistan 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
IL - Israele 2
LY - Libia 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
NG - Nigeria 1
NI - Nicaragua 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.402
Salva come PNG Salva come JPEG
Città #
Ashburn 447
Chandler 221
Jacksonville 212
Singapore 196
Fairfield 176
San Jose 130
New York 112
Dublin 110
Wilmington 101
Boardman 90
Dallas 87
Seattle 84
Woodbridge 84
Beijing 79
Ho Chi Minh City 70
Abidjan 50
The Dalles 49
Hong Kong 47
Houston 47
Cambridge 44
Lawrence 43
Princeton 43
San Mateo 43
Lauterbourg 41
Hanoi 38
Los Angeles 37
Munich 37
Centro 36
Moscow 34
Ann Arbor 31
San Diego 21
London 16
São Paulo 16
Da Nang 15
Hefei 15
Turku 15
Orem 14
Turin 14
Milan 13
Brooklyn 12
Chennai 12
Chicago 11
Helsinki 11
Warsaw 11
Guangzhou 10
Buffalo 9
Johannesburg 9
Pune 9
Rome 9
Santa Clara 9
Des Moines 8
Marche 8
Rio de Janeiro 8
Tokyo 8
Frankfurt am Main 7
Porto Alegre 7
Redmond 7
Shanghai 7
Stockholm 7
Haiphong 6
Manchester 6
Montegiorgio 6
Montreal 6
Naples 6
Poplar 6
Toronto 6
Wuxi 6
Ancona 5
Brussels 5
Cupra Marittima 5
Hải Dương 5
Norwalk 5
Phoenix 5
Porto 5
Quận Ba 5
San Francisco 5
Thái Nguyên 5
Washington 5
Atlanta 4
Baghdad 4
Belo Horizonte 4
Brasília 4
Curitiba 4
Jiaxing 4
Mexico City 4
Mumbai 4
Nuremberg 4
Amsterdam 3
Ankara 3
Biên Hòa 3
Boston 3
Cairo 3
Cape Town 3
Chiswick 3
City of London 3
Columbus 3
Guarulhos 3
Istanbul 3
Izmir 3
Kilburn 3
Totale 3.315
Salva come PNG Salva come JPEG
Nome #
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 198
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 194
Emerging biomarkers in bladder cancer identified by network analysis of transcriptomic data 184
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 181
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 165
Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience 162
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 160
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 159
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 156
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 152
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: ultrasound feature in case report 152
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 152
Metabolic Alterations in Renal and Prostate Cancer 151
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 139
PEC-OME of the prostate: case report 137
Diagnostic-therapeutic pathway for small lesions of the testis 132
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 132
Biomarkers for VEGF-targeted therapy in renal cell carcinoma: an UpTo Date 131
Present and future of personalized medicine in adult genitourinary tumors 131
Sphincter: properties, types and application 130
Repeated injection of botulinum toxin a in patients with neurogenic bladder: our experience. 127
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials 127
Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives. 125
NEPHRON-SPARING SURGERY FOR RENAL MASSES >4 CM (CT1B-T2) IN PATIENTS WITH CHRONIC RENAL FAILURE 123
Emerging concepts on drug resistance in bladder cancer: Implications for future strategies 119
Urinary catheters and biofilm formation 117
Role of STAT3 pathway in genitourinary tumors 113
Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma 112
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients 111
The route to personalized medicine in bladder cancer: where do we stand? 110
Efficacy and safety of alfa-1-blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a prospective study 107
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: A systematic review and meta-analysis 107
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy 106
Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors 103
Recurrent urinary tract infections and dysfunctional voiding 100
α1-Blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: A prospective randomized study. 100
Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasis 90
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma 90
VEGF and HIF in renal cell carcinogenesis. 86
Survival in Patients with Clear Cell Renal Cell Carcinoma is Predicted by HIF-1α Expression 85
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors 81
RESULTS OF NEPHRON-SPARING SURGERY WITHOUT VASCULAR CLAMPING IN PATIENTS WITH CHRONIC RENAL FAILURE 78
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma 65
Totale 5.480
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.572
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 0 0 0 0 0 37
2021/2022306 33 60 8 9 2 26 5 15 24 28 24 72
2022/2023636 58 94 44 48 48 53 3 40 168 8 48 24
2023/2024419 75 7 28 47 56 131 8 12 3 9 1 42
2024/2025710 101 53 11 10 54 22 62 21 145 43 87 101
2025/20261.929 169 141 80 182 256 144 317 214 166 128 59 73
Totale 5.480